Trial
NCT00429039
A Study to Accelerate Immune System Recovery Following Stem Cell Transplantation
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Collaborators
National Cancer Institute (NCI)
Condition
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Intervention
L-leucyl-L-leucine methyl ester (LLME)
Why stopped
Low accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-10-21